and damaging actions. NO in low (physiological) concentrations influences blood flow, immune functions and platelet aggregation, while higher concentrations (produced by the isoenzyme NOS2 or inducible NOS) are associated with pain, atherosclerosis, cancer, inflammatory and immunological disorders. 9 NO may have a role in tumour progression due to involvement of mechanisms such as DNA damage, tumour angiogenesis and tumour invasion and metastasis is also well appreciated.
Overall, the reported literature on different oxidative and inflammatory biomarkers in OLP and their potential role in the development of OLP is scarce and poorly documented. Since NO has oxidative, inflammatory and immunological properties, it is appropriate to investigate its potential role in OLP. The aim of this review was to present the current evidence on the potential role of NO as a biomarker of OLP.
| MATERIAL AND ME THODS

| Study protocol
The current systematic review was registered as a protocol with international prospective register of systematic reviews (PROSPERO) platform (ID: 118591), and it was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.
| Eligibility criteria
| Inclusion criteria
PECOS framework (Population, Exposure, Comparison, Outcomes, Studies) was used to formulate the focused question of the review, of which: P) Patients with diagnosis of OLP; E) NO detection; C)
Patients/participants with no history of OLP; O) Assessing association between NO and OLP; S) Observational studies.
Observational studies including case-control, cross-sectional or population-based that recruited patients with clinically and/or histologically confirmed diagnosis of OLP and evaluated the association of NO and OLP were included. Articles published in English language only were included. The study had a focused question."Is there an association between nitric oxide and OLP?"
| Exclusion criteria
The following exclusion criteria were applied: (a) Studies that did not evaluate the association between NO and OLP; (b) case reports, reviews, experimental studies, short communications and personal opinions, letters to the editor, and conference abstracts.
| Search strategy
Detailed automated literature searches were performed in PubMed, EMBASE, Scopus and Web of Science from January 1990 up to and 
| Study selection and data extraction
The study selection process was completed in two stages. Firstly, titles and abstracts of all identified articles were screened by two independent reviewers (KHA and SP). This was followed by retrieval of full texts for studies that met the eligibility criteria. These were reviewed independently by the same two reviewers using a standardized and pilot tested form. Any disagreements on study selection
were mutually discussed and a consensus was made before inclusion of the study.
The two reviewers (KHA and SP) independently collected the data on study characteristics (author, year of study and country), study design, sample population, NO detection and analysis methods, and outcome.
| Quality assessment of included studies
The quality of included studies was assessed using the NewcastleOttawa scale (NOS) ( Table 1) . 11 Two reviewers (KHA and SP) independently evaluated the quality of studies based on the following parameters: Selection, Comparability and Outcome/Exposure. A maximum of four stars in the selection domain, two stars in the comparability domain and three stars in the outcome/exposure domain were given. The included studies were qualified as "Good," "Fair" and "Poor" quality based on the total NOS score they achieved. Studies with a NOS score ≥7 and were considered good-quality studies.
| Statistical analysis
Cohen's kappa statistic was used to calculate the agreement between the two reviewers (KHA and SP). Statistically significant differences in NO levels between the two groups (case and control)
were reported. NOS scores based on the assessment of quality of each study were also reported.
| RE SULTS
| Study selection
Of 32 full texts assessed, 24 articles were excluded, and only seven papers that met the eligibility criteria were included ( Figure 1 and abstract screening stage) and 1.00 in the second stage (full-text reading stage).
| Studies characteristics
All of the included studies were case-control in nature and 151 patients with OLP were evaluated (mostly females), with an age ranged from 20 to 75 years. Of the seven included studies, [12] [13] [14] [15] [16] [17] [18] four were from India, [13] [14] [15] [16] and one each from Spain, 18 Iran 17 and Japan. 12 The majority of studies used whole unstimulated saliva [13] [14] [15] [16] 18 and one study used unstimulated gland saliva from parotid and submandibular glands collection of NO. 12 Since NO is so reactive, it cannot be measured directly and detection is by its reaction products. Griess assay was the most common method used for the analysis of NO. [12] [13] [14] [15] [16] 18 Only one study used serum and ELISA kit for the extraction and analysis of NO. 17 Table 2 provides the detailed characteristics of the included studies.
| Main findings
All of the included studies showed a significant higher NO levels in OLP patients compared to healthy controls. Two studies showed evidence for a higher NO levels in erosive than in non-erosive OLP.
13,14
The NOS score for the quality of the included studies ranged from 6 to 7. Only two studies 12,15 had a NOS score of "7" to be considered good-quality studies, while the remaining five studies 13, 14, [16] [17] [18] recorded a NOS score of "6." The majority of studies scored high in the selection domain and comparability domain was the least scored domain. The majority of studies also scored high in the outcome/ exposure domain.
| D ISCUSS I ON
In this study, we systematically reviewed the literature on the association of NO and OLP based on the view that cellular immunemediated mechanisms could act as predisposing factors for OLP. In addition, detection of these inflammatory biomarkers in OLP patients might aid the diagnosis and prognosis of the disease as well as identifying most effective therapeutic agents.
All of the included studies demonstrated a high NO saliva levels in OLP compared to healthy controls. The majority of studies collected saliva for the analysis of NO concentrations, while only one study 17 reported serum concentrations of NO via blood samples.
Saliva is a biofluid rich in antioxidants and can act as the first line of defense against oxidative stress. [19] [20] [21] [22] [23] The majority of studies used
Griess assay method for the measurement of NO levels, while one study 17 employed Human NO ELISA kit (Cusabio; USA) and ELISA apparatus (ELISA micro plate reader; BIOTEK, Winooski, VT) to measure the NO levels.
Although the exact role of NO in the aetiology and pathogenesis of OLP is not known, a possible role has been proposed. 12, 24, 25 OLP patients often report increased levels of stress during the onset or higher concentration of NO. 26, 27 The increased NO in saliva could result in oxidative stress on reactive nitrogen species (RNS) by increasing the oxidant generation and decreasing the antioxidant protection, thus correlating indirectly to OLP. [28] [29] [30] In addition, increased NO leads to cell damage, tissue injury and organ failure. Studies have reported that increase in NO can lead to damage to fibroblasts, keratinocytes and oral epithelial cells in vitro. 11, 12 While assessing quality of the included studies using NOS score, only two studies were classified as good quality. 12, 15 Both of these reported OLP cases that were confirmed either through clinical and/or histopathological analysis, had consecutive representative series of cases and controls with no history of disease. In addition, the same method of ascertainment was used for both patients and controls. In contrast, studies that scored low on NOS did not match the controls based on age/sex and location use hospital patients for their controls.
There are a few limitations to the current review. Firstly, the level of evidence was low in the included studies. None of the studies had recruited controls from the same community as the patients and failed to match them in terms of age, sex and location. In addition, the inclusion criteria were not very stringent in many of the studies presented. Lastly, lack of the assessment of heterogeneity and a fully comprehensive meta-analysis further undermine the quality of this review.
| CON CLUS ION
The findings support an association of increased salivary NO in OLP patients. Assessment of these biomarkers in OLP patients could be 
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